Amelubant
CAS: 346735-24-8
Ref. 3D-WNA73524
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar |
Información del producto
- Biil-284
- Carbamic acid, N-[[4-[[3-[[4-[1-(4-hydroxyphenyl)-1-methylethyl]phenoxy]methyl]phenyl]methoxy]phenyl]iminomethyl]-, ethyl ester
- Carbamic acid, [[4-[[3-[[4-[1-(4-hydroxyphenyl)-1-methylethyl]phenoxy]methyl]phenyl]methoxy]phenyl]iminomethyl]-, ethyl ester
- ethyl {(E)-[(4-{[3-({4-[2-(4-hydroxyphenyl)propan-2-yl]phenoxy}methyl)benzyl]oxy}phenyl)amino]methylidene}carbamate - ethane (1:1)
Amelubant is a covalent leukotriene receptor antagonist that inhibits the binding of leukotrienes to their receptors. It is used for the treatment of bowel disease, such as inflammatory bowel disease. Amelubant also has affinity ligands and is active against eosinophil cationic protein. This drug has a degradable side chain and does not have an active metabolite. It binds to the leukotriene receptor and prevents it from activating, thereby inhibiting the release of pro-inflammatory mediators. Amelubant has been shown to be effective in clinical trials for the treatment of inflammatory bowel disease, with no major adverse effects.
Propiedades químicas
Consulta técnica sobre: 3D-WNA73524 Amelubant
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
